Advaxis (ADXS) Announces Clinical Hold in Axalimogene Filolisbac Phase 1/2 Combination Study with AstraZeneca's (AZN) IMFINZI

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. HOOD
9. DFTX
10. IBM

Go back to Advaxis (ADXS) Announces Clinical Hold in Axalimogene Filolisbac Phase 1/2 Combination Study with AstraZeneca's (AZN) IMFINZI
ADVAXIS (AMEX: ADXS) Delayed: 0.60 --0 (-0%)
Previous Close $0.60    52 Week High $16.30 
Open $0.60    52 Week Low $5.21 
Day High $0.60    P/E N/A 
Day Low $0.60    EPS $-4.10 
Volume 33,238,751       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 1,489,609